Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tradipitant in Gastroparesis
NCT02970968Phase 2Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Nov 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in gastroparesis comparing Tradipitant with Placebo (2 arms). Primary endpoint: Change From Baseline in Average Nausea Severity at 4 weeks. Started Nov 2016; status: completed.
02
Drugs
tradipitant
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT02970968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02970968.